Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine Feb/03/2022 60 0
mRNA-1273 Emergency use authorization Experimental Vaccine Feb/03/2022 25 0
Imdevimab Emergency use authorization Experimental Antiviral Jan/26/2022 9 8
Casirivimab Emergency use authorization Experimental Antiviral Jan/26/2022 4 11
Bamlanivimab Potential treatment - clinical evidence Experimental Antiviral Jan/25/2022 4 12
REGEN-COV Emergency use authorization Experimental Antiviral Aug/19/2021 4 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 92 22
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021 12 1
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/09/2021 16 8
Grazoprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/31/2021 4 1